New York, July 25, 2022 (GLOBE NEWSWIRE) — The Insight Partners published latest research study on “Colorectal Cancer Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality, End User, and Geography,” increasing cases of colorectal cancer and a rise in the aging population are driving the market growth. However, the high cost of colorectal cancer diagnostic equipment is hampering the market growth.
Request Sample PDF Copy of Colorectal Cancer Market Size – COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.theinsightpartners.com/sample/TIPRE00006881/
Colorectal Cancer Market Report Scope & Strategic Insights:
| Report Coverage | Details |
| Market Size Value in | US$ 18.6193 billion in 2022 |
| Market Size Value by | US$ 24.0785 billion by 2028 |
| Growth rate | CAGR of 3.3% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
| No. of Pages | 259 |
| No. Tables | 193 |
| No. of Charts & Figures | 90 |
| Historical data available | Yes |
| Segments covered | Modality, and End User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Global Colorectal Cancer Market: Competitive Landscape and Key Developments
Amgen Inc., Bruker Corporation, Epigenomics Ag, Clinical Genomics Technologies Pty Ltd., Volitionrx Limited, Novigenix, F. Hoffman LA….
